Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 7654321, 8 pages
http://dx.doi.org/10.1155/2016/7654321
Research Article

Epigenetic Induction of Definitive and Pancreatic Endoderm Cell Fate in Human Fibroblasts

1Interdepartmental Stem Cell Institute, Department of Development and Regeneration, Stem Cell Biology and Embryology, KU Leuven, 3000 Leuven, Belgium
2University Medical Center Groningen (UMCG), Pathology and Medical Biology, Section of Immunoendocrinology, University of Groningen, Hanzeplein 1, EA 11, 9713 GZ Groningen, Netherlands

Received 12 January 2016; Revised 22 April 2016; Accepted 8 May 2016

Academic Editor: Andrzej Lange

Copyright © 2016 Rangarajan Sambathkumar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Reprogramming can occur by the introduction of key transcription factors (TFs) as well as by epigenetic changes. We demonstrated that histone deacetylase inhibitor (HDACi) Trichostatin A (TSA) combined with a chromatin remodeling medium (CRM) induced expression of a number of definitive endoderm and early and late pancreatic marker genes. When CRM was omitted, endoderm/pancreatic marker genes were not induced. Furthermore, treatment with DNA methyltransferase inhibitor (DNMTi) 5-azacytidine (5AZA) CRM did not affect gene expression changes, and when 5AZA was combined with TSA, no further increase in gene expression of endoderm, pancreatic endoderm, and endocrine markers was seen over levels induced with TSA alone. Interestingly, TSA-CRM did not affect expression of pluripotency and hepatocyte genes but induced some mesoderm transcripts. Upon removal of TSA-CRM, the endoderm/pancreatic gene expression profile returned to baseline. Our findings underscore the role epigenetic modification in transdifferentiation of one somatic cell into another. However, full reprogramming of fibroblasts to β-cells will require combination of this approach with TF overexpression and/or culture of the partially reprogrammed cells under -cell specific conditions.